ApiJect, a young injections company focused on the developing world, never wanted to work in America. Now they've got the biggest U.S. government contract to help deliver a COVID-19 vaccine. Read more from AP, frontlinepbs and GlobalRepCentre
FILE - In this March 16, 2020, file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. When precious vats of COVID-19 vaccine are finally ready, the ability to jab the lifesaving solution into the arms of Americans will require hundreds of millions of injections.
Trump administration officials would not say why they are investing so heavily in ApiJect’s technology. The company has made only about 1,000 prototypes to date, and it’s not clear whether those devices can deliver the vaccines that are currently in development. So far, the leading candidates are using traditional vials to hold the vaccine, and needles and syringes in their clinical trials.ApiJect founder Marc Koska never intended to vaccinate the United States.
According to Walker, the CEO, ApiJect wasn’t interested in a federal contract — they were aiming to change the developing world with quick, inexpensive injection devices that could save millions of lives. Walker continued to resist, he said, but Giroir — who is also a doctor specializing in pediatric critical care — “wasn’t big on taking no for an answer,” Walker said.
When the pandemic emerged weeks later, officials sounded the alarm about a potential shortage of needles and syringes to deliver a vaccine if and when one became available.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. Governors Call For Trump Administration To Renew Its Public Health Emergency Amid Covid-19 Surge'Without these options, governors’ ability to protect the health and safety of their residents will be reduced at a critical time,' the statement reads.
Read more »
Website to volunteer for Covid-19 vaccine trials in US is now liveThe coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.
Read more »
Covid-19 Vaccine Trials Now Open To Volunteers In U.S.The National Institute of Allergy and Infectious Diseases launched the website Covid-19 Prevention Network on Wednesday, merging four existing clinical trial networks and setting up an operation across over 100 different sites in the United States and internationally.
Read more »
More than 58,000 cases of Covid-19 were reported in the US WednesdayThe coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.
Read more »
Covid-19 Vaccine Trials Now Open To Volunteers In U.S.The National Institute of Allergy and Infectious Diseases launched the website Covid-19 Prevention Network on Wednesday, merging four existing clinical trial networks and setting up an operation across over 100 different sites in the United States and internationally.
Read more »
As Vaccine Skepticism In U.S. Grows, Experts Recommend Strategies For Covid-19 Vaccination CampaignPolling suggests only 50% of the population would get a Covid-19 vaccine were it available.
Read more »